Skip to main content
IntroMedic Co., Ltd. logo

IntroMedic Co., Ltd. — Investor Relations & Filings

Ticker · 150840 ISIN · KR7150840007 KO Manufacturing
Open in API
Filings indexed 442 across all filing types
Latest filing 2023-03-15 Proxy Solicitation & In…
Country KR South Korea
Listing KO 150840

About IntroMedic Co., Ltd.

http://www.intromedic.com/

IntroMedic Co., Ltd. is a medical device company that develops, manufactures, and distributes capsule endoscopy products. Established in 2004, the company's core offering is the MiroCam® capsule endoscope system. This system is designed as a tool for the detection of abnormalities within the small bowel in both adult and pediatric patients from two years of age. IntroMedic operates through a global network of partner companies to distribute its medical equipment.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and contains information regarding the solicitation of proxies for the 19th Annual General Meeting of Shareholders of Intromedic Co., Ltd. It includes details about the meeting date, agenda items (such as approval of financial statements), and instructions for shareholders to exercise their voting rights. This document is a standard proxy solicitation statement used to request shareholder votes for an upcoming meeting.
2023-03-15 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short, official announcement detailing the results of an Extraordinary General Meeting (임시주주총회결과), specifically noting that a resolution was rejected due to a lack of quorum. This falls under the category of Declaration of Voting Results.
2023-02-17 Korean
파생상품거래손실발생
Capital/Financing Update Classification · 100% confidence The document is a regulatory disclosure regarding a 'Loss from Derivatives Transaction' (파생상품거래손실발생) filed by Intromedic. It details the accounting-based valuation loss related to convertible bonds, which is a specific regulatory disclosure requirement in the Korean market (DART system). Since it does not fit into specific categories like M&A, dividends, or share repurchases, and is a formal regulatory announcement of a material event, it is classified as a Regulatory Filing (RNS).
2023-02-16 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company Intromedic. It outlines the date, location, and the agenda items (such as approval of financial statements, amendments to articles of incorporation, and director compensation). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming votes, which falls under the Proxy Solicitation & Information Statement category.
2023-02-16 Korean
내부결산시점관리종목지정ㆍ형식적상장폐지ㆍ상장적격성실질심사사유발생
Delisting Announcement Classification · 100% confidence The document is a regulatory filing from a Korean company (IntroMedic) regarding 'Management Item Designation' and 'Delisting/Qualification Review' triggers based on internal financial results. It provides detailed financial tables (balance sheet, income statement, and loss ratios) for the current and previous fiscal years. This type of disclosure is a standard regulatory announcement in the Korean market (DART system) regarding financial status and potential listing risks, which falls under the 'Regulatory Filings' category as it is a mandatory disclosure of material financial events.
2023-02-16 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a regulatory filing from Intromedic regarding the 'Resolution to Convene a General Meeting of Shareholders' (주주총회소집결의). It provides details on the date, location, and agenda items for an Extraordinary General Meeting (EGM), including amendments to business purposes. Since this document serves as the official notice and proxy-related information for shareholders regarding an upcoming meeting, it falls under the Proxy Solicitation & Information Statement category.
2023-02-02 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.